Clinical Trials Logo

Filter by:
NCT ID: NCT00838292 Completed - HIV Infections Clinical Trials

Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya

Start date: August 2006
Phase: N/A
Study type: Interventional

The purpose of the study is to test whether food supplementation of malnourished HIV-infected adults (both pre-ART and ART) in resource constrained settings improves their nutritional status, clinical status, effectiveness of treatment, quality of life, functioning, and survival.

NCT ID: NCT00830622 Completed - HIV Infections Clinical Trials

Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya

Start date: May 2007
Phase: N/A
Study type: Interventional

A clinical study to evaluate the use of cell phones to support drug adherence and follow-up of patients taking antiretroviral therapy (ART) for treatment of HIV. The intervention involves health-care providers sending regular short-message-service (SMS) text messages to patients and following up their responses. The hypothesis is that the cell phone intervention will improve ART adherence and health outcomes compared with the current standard of care.

NCT ID: NCT00820261 Completed - Rotavirus Clinical Trials

Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya

Rotavirus
Start date: August 2009
Phase: N/A
Study type: Observational

Rotavirus is the most common cause of severe infantile diarrhoea disease in infants and young children below five years worldwide. It is associated with high cases of morbidity and mortality and it is estimated that up to 600,000 deaths in young children occur annually in the less developed countries and approximately 150,000-200,000 deaths occur in Africa alone. In Kenya, most rotavirus surveillance work has been done in Nairobi (an urban setting). Other parts e.g eastern Kenya, limited data is available and hence the prevalence and burden of rotavirus disease is under-estimated. We therefore hypothesize that rotavirus prevalence is high in Meru,Maua (a rural setting)and hence we designed a study to evaluate this. This is a prospective study to determine, the rotavirus disease burden and epidemiology in infants and children with severe diarrhoea hospitalized in three sentinel hospital in the eastern part of Kenya (Maua Methodist hospital) will be carried out during the period January 2009 to December 2010. Faecal samples will be collected from infants and children admitted with acute diarrhoea and screened first for the presence of human serotype A rotavirus antigen using commercially available enzyme linked immunosorbent assay kit (ELISA). The positive samples will be evaluated by sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) to determine the electropherotypes and genotyped using reverse transcriptase polymerase chain reaction (RT-PCR) on VP7 and VP4 gene. These data/ results generated from this project will add crucial information on the rotavirus strains circulating in the eastern part of Kenya.

NCT ID: NCT00811421 Completed - HIV Infections Clinical Trials

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

MiPPAD
Start date: September 2009
Phase: N/A
Study type: Interventional

The study aims at comparing the safety, tolerability and efficacy of Mefloquine (MQ) to Sulfadoxine-Pyrimethamine (SP) as Interment Preventive Treatment in pregnancy (IPTp) for the prevention of malaria effects on the mother and her infant.

NCT ID: NCT00799864 Completed - HIV-1 Clinical Trials

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Activity of Rilpivirine (TMC278) in Human Immunodeficiency Virus Infected Adolescents and Children Aged Greater Than or Equal to 6 Years

Start date: January 7, 2011
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the pharmacokinetics, safety and antiviral activity of rilpivirine (TMC278) 25 milligram (mg) or adjusted dose once daily in combination with an investigator-selected background regimen containing 2 nucleoside/nucleotide reverse transcriptase inhibitors (N[t]RTIs) (zidovudine [AZT], abacavir [ABC], or tenofovir disoproxil fumarate [TDF] in combination with lamivudine [3TC] or emtricitabine [FTC] in antiretroviral (ARV) treatment-naïve adolescents and children aged greater than or equal to (>=) 6 to less than (<) 18 years.

NCT ID: NCT00792519 Completed - HIV Infections Clinical Trials

Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans

KHBS
Start date: February 2009
Phase: Phase 1
Study type: Interventional

This study will determine whether a cognitive behavioral intervention that demonstrates strong evidence in the U.S. of reducing alcohol use is effective when delivered by paraprofessionals in Kenya and compared against a usual care support group.

NCT ID: NCT00791531 Completed - Malaria Clinical Trials

Assessment of Safety and Pharmacokinetics of a Low Dose of Methotrexate in Healthy Adult Male Kenyan Volunteers

Start date: March 2009
Phase: Phase 1
Study type: Interventional

Previous investigations indicate that methotrexate, an old anticancer drug, could be used at low doses to treat malaria. This is a phase I evaluation to assess the safety and pharmacokinetic profile of this drug in healthy adult male Kenyan volunteers.

NCT ID: NCT00730938 Completed - Cataract Clinical Trials

The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery

Start date: February 2008
Phase: N/A
Study type: Interventional

The study investigates whether placing an antibiotic inside the eye at the end of cataract surgery in children will reduce the amount of fibrin formation (fibrin formation can block the pupil and reduce vision). We hypothesize that the fibrin is caused by a low-level infection and could be prevented by the antibiotic.

NCT ID: NCT00709969 Completed - Clinical trials for Plasmodium Falciparum Malaria

Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Start date: July 2002
Phase: Phase 3
Study type: Interventional

This study will assess the safety and efficacy of artemether-lumefantrine tablets (6-dose regimen) in African infants / children with acute uncomplicated falciparum malaria.

NCT ID: NCT00677833 Completed - Malaria, Falciparum Clinical Trials

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

Start date: June 2008
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective is to confirm the hypothesis that azithromycin used in combination with chloroquine is non-inferior to artemether- Lumefantrine for the treatment of symptomatic, uncomplicated malaria due to P. falciparum in children in African countries.